# FDA Inspection 661172 - Legacy Pharmaceuticals Switzerland GmbH - March 30, 2010

Source: https://www.keypedia.com/records/fda_inspections/legacy-pharmaceuticals-switzerland-gmbh/1b1f31a0-0d08-48c9-85e1-cad3160fdf78
Source feed: FDA_Inspections

> FDA Inspection 661172 for Legacy Pharmaceuticals Switzerland GmbH on March 30, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 661172
- Company Name: Legacy Pharmaceuticals Switzerland GmbH
- Inspection Date: 2010-03-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1018900 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceuticals-switzerland-gmbh/d687ff6c-8625-4830-98d4-e5a2f1f54816)

Company: https://www.keypedia.com/companies/legacy-pharmaceuticals-switzerland-gmbh/12fbec96-87c8-4cc5-9c5d-f13acd0766f8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c